Ambalavanan, Namasivayam
- Lurie Children's Hospital of Chicago · Pediatrics (investigator's affiliation)
- Prapela, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,697
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2004 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#3,697
By linked amount among FY2023 PIs
Earliest Year Loaded
2004
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Ambalavanan, Namasivayam as a PI. Multi-PI records show the full award amount for context.
- 5R01HL157256-02R01Contact PIPost-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School AgeLurie Children's Hospital of Chicago · Pediatrics (investigator's affiliation)$1.5Maward amount
- 1U44DA059380-01U44Contact PIPrapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.$500.2Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Ambalavanan, Namasivayam as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2004First NIH AwardLurie Children's Hospital of Chicago
- 2005Multi-Institutional ResearchAwards at 2 institutions
- 2011$500K Cumulative Funding
- 2012$1M Cumulative Funding
- 2012R01 Grant Holder
- 2013$2M Cumulative Funding
- 2022$5M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #5721
- 2023Entered Top 25% NationallyRanked #3697